<?xml version="1.0" encoding="UTF-8"?>
<p>SHARED participants were recruited from four HCV treatment centers in Rwanda and treated at a single study site (Rwanda Military Hospital, Kigali, Rwanda). Eligible participants were 18 years or older with chronic HCV GT 1 or 4 infection with a serum HCV RNA ≥ 1,000 IU/mL. Participants were required to have a baseline hemoglobin ≥ 8.0 g/dL; platelets ≥ 40,000/mm
 <sup>3</sup>; aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase ≤ 10 times the upper limit of normal; and a calculated creatinine clearance ≥ 30 mL/minute, as estimated by the Cockcroft‐Gault equation.
</p>
